Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors
NCT04916249Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2021
- Primary completion
- May 2027
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 2 trial of Qizheng Xiaotong Plaster in Musculoskeletal pain, sponsored by Memorial Sloan Kettering Cancer Center. Started May 2021; status: active, not recruiting.
02
Drugs
Qizheng Xiaotong Plaster
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT04916249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916249.